MedPath

A Comparative Pilot study on Medicated fumigation Wick with and without internal medicine of Gowri chinthamani chendhuram in the treatment of Sinusitis

Phase 3
Completed
Conditions
KABHA PEENISAM (SINUSITIS)
Registration Number
CTRI/2018/04/013132
Lead Sponsor
AYOTHIDOSS PANDITHAR HOSPITAL
Brief Summary

It is a single non randomized open lable trial to determine the efficacy and safety of peenisa thiri (external medicine) with and without gowri chinthamani chenthooram (internal medicine )in patients with kabha peenisam (sinusitis).in this trial 20 patients will be recruited. the trial drug gowri chinthamani chenthooram 200mg twice a dayand peenisa thiri will be administered for 10 patients and the external medicine peenisa thiri will be administered for 10 patients for a period of 24 days.during the trial period if any AE/SAE/SUSAR will be noticed and refered to pharmacovigilance dept of NIS and further management will also be given in NIS OPD/IPD. The entire trial will be monitor by the research monitoring commitee of NIS.During this trial all the safety and efficacy parameter will be recorded in CRF.After completion of the trial all this study related data will be analysed statistically.The outcome of this trial will be puplished in indian journal of medical research.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria
    1. Patients who having the symptoms of pain in the face , purulent nasal discharge , head ache or heaviness of head , sneezing , fever , tooth ache , nasal block and presence of any three symptoms.
    1. Patient willing to sign the informed consent stating that he / she will conscientiously stick to the treatment during 24 days but can opt out of the trial of his / her own conscious discretion 3) Patients who are willing for radiological investigations (Xray for Paranasal sinuses) and provide blood , urine for lab investigations.
Exclusion Criteria

1)H/O Bronchial asthma 2)H/O Tuberculosis 3)H/O Diabetes mellitus 4)H/O Hypertension 5)H/O Heart disease 6)H/O Chronic obstructive pulmonary disease 7)H/O Thyroidism 8)H/O Renal disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the therapeutic efficacy of "Peenisa thiri" (Medicated fumigation wick) with and without "Gowri chinthamani chenthooram" (Internal) for the changes in the lab parameters in "Kabha peenisam" (Sinusitis)To compare the therapeutic efficacy of "Peenisa thiri" (Medicated fumigation wick) with and without "Gowri chinthamani chenthooram" (Internal) for the changes in the lab parameters in "Kabha peenisam" (Sinusitis) for a period of 24 days
Secondary Outcome Measures
NameTimeMethod
1)To study the reduction in clinical symptoms and changes in lesion in radiological investigation2)To study the siddha principles such as 3 humours, Naadi, 8 diagnostic method, Neerkuri, Nei kuri, 7 body constituents etc..

Trial Locations

Locations (1)

Ayothidoss Pandithar Hospital

🇮🇳

Kancheepuram, TAMIL NADU, India

Ayothidoss Pandithar Hospital
🇮🇳Kancheepuram, TAMIL NADU, India
DRMSUGANTHI
Principal investigator
8056786753
drsuganthi6@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.